Andrea Goren - Jun 14, 2021 Form 3 Insider Report for INVO Bioscience, Inc. (INVO)

Signature
/s/ Andrea Goren
Stock symbol
INVO
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/21/2021, 06:11 PM
Next filing
Oct 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INVO Common Stock 12.5K Jun 14, 2021 Direct
holding INVO Common Stock 45.7K Jun 14, 2021 Via Andax LLC
holding INVO Common Stock 5K Jun 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INVO Stock Option Jun 14, 2021 Common Stock 72.5K $5.13 Direct F2
holding INVO Stock Option Jun 14, 2021 Common Stock 163K $5.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units, which vest in substantially equal monthly increments over a period of 12 months from the grant date of June 14, 2021.
F2 The option will not commence vesting or be exercisable until the Issuer has sufficient shares available under its 2019 Stock Incentive Plan on January 1, 2022 in accordance with the annual increase provisions contained in Section 4.2 thereunder, at which time 12,083 shares underlying the option will vest and the remainder will vest monthly over a 3-year period.
F3 The option vests in monthly increments over a 3-year period from the date of grant.